The antibody used specifically reacts with human CD31 and the specificity was rigorously validated using murine kidney tissue as a negative control and human renal glomeruli from adjacent tissues of renal cell carcinoma as a positive control (Fig. S6d). This evidence concerns the gene PECAM1 and renal cell carcinoma.